Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

Cited In for PubMed (Select 21876675)

1.

Widespread intron retention diversifies most cancer transcriptomes.

Dvinge H, Bradley RK.

Genome Med. 2015 May 15;7(1):45. doi: 10.1186/s13073-015-0168-9. eCollection 2015.

2.

Menacalc, a quantitative method of metastasis assessment, as a prognostic marker for axillary node-negative breast cancer.

Forse CL, Agarwal S, Pinnaduwage D, Gertler F, Condeelis JS, Lin J, Xue X, Johung K, Mulligan AM, Rohan TE, Bull SB, Andrulis IL.

BMC Cancer. 2015 Jun 27;15:483. doi: 10.1186/s12885-015-1468-6.

3.

Identification of recurrent regulated alternative splicing events across human solid tumors.

Danan-Gotthold M, Golan-Gerstl R, Eisenberg E, Meir K, Karni R, Levanon EY.

Nucleic Acids Res. 2015 May 26;43(10):5130-44. doi: 10.1093/nar/gkv210. Epub 2015 Apr 23.

4.

EMT and tumor metastasis.

Heerboth S, Housman G, Leary M, Longacre M, Byler S, Lapinska K, Willbanks A, Sarkar S.

Clin Transl Med. 2015 Feb 26;4:6. doi: 10.1186/s40169-015-0048-3. eCollection 2015.

5.
6.

Mapping Splicing Quantitative Trait Loci in RNA-Seq.

Jia C, Hu Y, Liu Y, Li M.

Cancer Inform. 2015 Feb 16;14(Suppl 1):45-53. doi: 10.4137/CIN.S24832. eCollection 2015.

7.

Regulation of epithelial-mesenchymal transition in breast cancer cells by cell contact and adhesion.

Cichon MA, Nelson CM, Radisky DC.

Cancer Inform. 2015 Feb 9;14(Suppl 3):1-13. doi: 10.4137/CIN.S18965. eCollection 2015.

8.

RNA toxicity and missplicing in the common eye disease fuchs endothelial corneal dystrophy.

Du J, Aleff RA, Soragni E, Kalari K, Nie J, Tang X, Davila J, Kocher JP, Patel SV, Gottesfeld JM, Baratz KH, Wieben ED.

J Biol Chem. 2015 Mar 6;290(10):5979-90. doi: 10.1074/jbc.M114.621607. Epub 2015 Jan 15.

9.

Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome.

Madan V, Kanojia D, Li J, Okamoto R, Sato-Otsubo A, Kohlmann A, Sanada M, Grossmann V, Sundaresan J, Shiraishi Y, Miyano S, Thol F, Ganser A, Yang H, Haferlach T, Ogawa S, Koeffler HP.

Nat Commun. 2015 Jan 14;6:6042. doi: 10.1038/ncomms7042.

10.

Epithelial cell polarity determinant CRB3 in cancer development.

Li P, Mao X, Ren Y, Liu P.

Int J Biol Sci. 2015 Jan 1;11(1):31-7. doi: 10.7150/ijbs.10615. eCollection 2015.

11.

A posttranscriptional mechanism that controls Ptbp1 abundance in the Xenopus epidermis.

Méreau A, Anquetil V, Lerivray H, Viet J, Schirmer C, Audic Y, Legagneux V, Hardy S, Paillard L.

Mol Cell Biol. 2015 Feb;35(4):758-68. doi: 10.1128/MCB.01040-14. Epub 2014 Dec 15.

PMID:
25512611
12.

Histone H3.3 and cancer: A potential reader connection.

Lan F, Shi Y.

Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):6814-9. doi: 10.1073/pnas.1418996111. Epub 2014 Dec 1.

13.

Mapping Splicing Quantitative Trait Loci in RNA-Seq.

Jia C, Hu Y, Liu Y, Li M.

Cancer Inform. 2014 Oct 15;13(Suppl 4):35-43. doi: 10.4137/CIN.S13971. eCollection 2014.

14.

Invasive breast carcinoma cells from patients exhibit MenaINV- and macrophage-dependent transendothelial migration.

Pignatelli J, Goswami S, Jones JG, Rohan TE, Pieri E, Chen X, Adler E, Cox D, Maleki S, Bresnick A, Gertler FB, Condeelis JS, Oktay MH.

Sci Signal. 2014 Nov 25;7(353):ra112. doi: 10.1126/scisignal.2005329.

15.

Building robust transcriptomes with master splicing factors.

Jangi M, Sharp PA.

Cell. 2014 Oct 23;159(3):487-98. doi: 10.1016/j.cell.2014.09.054. Review.

PMID:
25417102
16.

Musashi proteins are post-transcriptional regulators of the epithelial-luminal cell state.

Katz Y, Li F, Lambert NJ, Sokol ES, Tam WL, Cheng AW, Airoldi EM, Lengner CJ, Gupta PB, Yu Z, Jaenisch R, Burge CB.

Elife. 2014 Nov 7;3:e03915. doi: 10.7554/eLife.03915.

17.

CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression.

Li L, Liu C, Amato RJ, Chang JT, Du G, Li W.

Oncotarget. 2014 Nov 15;5(21):10840-53.

18.

Transcriptome-wide landscape of pre-mRNA alternative splicing associated with metastatic colonization.

Lu ZX, Huang Q, Park JW, Shen S, Lin L, Tokheim CJ, Henry MD, Xing Y.

Mol Cancer Res. 2015 Feb;13(2):305-18. doi: 10.1158/1541-7786.MCR-14-0366. Epub 2014 Oct 1.

PMID:
25274489
19.

Epithelial splicing regulatory proteins 1 (ESRP1) and 2 (ESRP2) suppress cancer cell motility via different mechanisms.

Ishii H, Saitoh M, Sakamoto K, Kondo T, Katoh R, Tanaka S, Motizuki M, Masuyama K, Miyazawa K.

J Biol Chem. 2014 Oct 3;289(40):27386-99. doi: 10.1074/jbc.M114.589432. Epub 2014 Aug 20.

PMID:
25143390
20.

Identification of genetic variants associated with alternative splicing using sQTLseekeR.

Monlong J, Calvo M, Ferreira PG, Guigó R.

Nat Commun. 2014 Aug 20;5:4698. doi: 10.1038/ncomms5698.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk